Navigation Links
Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
Date:5/16/2008

- Speakers include industry and customer thought leaders -

SAN FRANCISCO, May 16 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trial management systems this week hosted a constellation of prestigious academic medical centers, research institutions and industry partners at its annual user group meeting in San Francisco. The Velos eResearch system allows customers to internally and collaboratively manage thousands of clinical trials.

Over 140 professionals, including representatives from institutions such as Cleveland Clinic Foundation, Duke University, MD Anderson, UCLA, University of Miami, and University of Michigan, attended this week's meeting at San Francisco's Hyatt Regency Hotel. Also in attendance were representatives from the pharmaceutical and biotech industries. Such themes as collaboration, direct data capture, multi-site research network management, outcomes measurement, patient self-reporting, and financial management, were discussed throughout the two-day session.

"We're delighted to see continued strong growth in the Velos customer base," said John S. McIlwain, President and CEO of Velos. "Attendance again increased more than 40 percent this year and approximately tenfold since our first user group meeting in 2005. The company's success in managing this growth is supported by the enthusiasm and passion of our customers. This year's meeting has been highlighted by customer willingness to share experiences and accomplishments and to collaborate in adopting state-of-the-art clinical research system infrastructure. We believe that this exceptional and growing customer base is increasingly positioned to move the industry forward as a whole."

A South Korean delegation was an eager participant in the many sessions. South Korea is deploying the Velos eResearch system in an unprecedented countrywide initiative that allows seamless clinical trials collaboration and information sharing among all South Korean cancer centers.

Velos U.S. customers receive over 30 percent of extramural clinical research funding from the National Institutes of Health, among the 100 largest such recipients -- the largest such share among clinical trial management system software vendors. The National Cancer Institute grants approximately 40 percent of its extramural funding to such Velos customers, also the largest such share. The Velos eResearch customer base includes 21 top 25* U.S. medical centers.

Speakers included representatives from the University of California Davis, Cleveland Clinic, Dartmouth University, Mary Crowley Cancer Centers, University of Miami, University of Michigan, and Northwestern University. Priti Sahai, MD, Velos Vice President of Product Development introduced a range of new system features, tools, and integrated product offerings, including Velos eResearch Version 8. "We were very pleased by the customer response to Version 8.0," observed Sahai. "It's gratifying to know that we continue to be on the right track and that our focus on product innovation is paying off for our customers."

"The highly regarded research centers who are Velos customers provide essential support for much-needed improvements in the information model in clinical research," noted Amar Chahal, MD, Velos Co-Founder and Executive Vice President. "These Velos customers have the knowledge, resources, and incentive to facilitate positive change. We've witnessed these dynamics in action this week here in San Francisco."

About Velos

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit http://www.velos.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.

*U.S. News & World Report, Best Hospitals Survey


'/>"/>
SOURCE Velos, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
2. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
3. Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
4. New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
5. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
6. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
7. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
8. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... Uro/Gyn and Gynecology markets with innovative and proprietary ... the Company as Senior Vice President, Marketing & ... Keswani will report directly to Darin Hammers ... is delighted that Ash has joined the Cogentix ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new patients ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients can ... more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored ... 2.0 — the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. ... telemedicine to improve the lives of the poor and underserved in other parts of ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection of ... is proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder ... of the Board and launched a national search to find a visionary new leader to ...
Breaking Medicine News(10 mins):